All In MedTech

Device Trial Radar · NCT02761499

Post Approval Study of the Commercially Available U-Motion II+ Acetabular System and UTF Reduced Stem

Prospective Post Approval Clinical Follow-Up Study of the Commercially Available U-Motion II+ Acetabular System and UTF Reduced Stem

Last checked: Nov 20, 2026Latest source record: Jun 5, 2023 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

200

Planned (sponsor's estimate)

Start

Jan 2016

Primary completion

Aug 2023

Study completion Aug 2025

Sponsor

Lead sponsor
United Orthopedic CorporationNot on our public-company list
Sponsor type
Industry
First posted
May 4, 2016

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a prospective, single arm, multi-center, post-approval study designed to evaluate the short and long term clinical performance and safety in subjects receiving primary total hip arthroplasty (THA) with the U-Motion II+ Acetabular System and UTF Reduced Stem.

Conditions

  • Osteoarthritis

Interventions

  • U-Motion II+ Acetabular SystemDevice

    U-Motion II+ Acetabular System (1) U-Motion II+ acetabular cup, (2) U-Motion II+ acetabular liner, (3) Cobalt-Chrome or BIOLOX delta ceramic femoral heads, and the 4) UTF Reduced Stem

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Operative SuccessTime frame: 2 Years

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Jacksonville Orthopaedic Institute

    Jacksonville, Florida

5 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.